Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
241.2 CHF | -3.60% | +1.68% | -7.65% |
08:14am | Correction to Roche Article | DJ |
07:50am | Roche Sales Decline on Currency Hit | DJ |
Sales 2024 * | 60.03B 65.81B | Sales 2025 * | 63.55B 69.67B | Capitalization | 185B 203B |
---|---|---|---|---|---|
Net income 2024 * | 13.27B 14.55B | Net income 2025 * | 14.64B 16.05B | EV / Sales 2024 * | 3.31 x |
Net Debt 2024 * | 13.62B 14.93B | Net Debt 2025 * | 7.57B 8.3B | EV / Sales 2025 * | 3.04 x |
P/E ratio 2024 * |
13.7
x | P/E ratio 2025 * |
12.3
x | Employees | 103,605 |
Yield 2024 * |
4.21% | Yield 2025 * |
4.36% | Free-Float | 88.91% |
Latest transcript on Roche Holding AG
1 day | +2.46% | ||
1 week | +5.21% | ||
Current month | +2.96% | ||
1 month | +5.57% | ||
3 months | -4.72% | ||
6 months | -1.26% | ||
Current year | -4.28% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 02-12-31 | |
Severin Schwan
CHM | Chairman | 57 | 07-12-31 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 11-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 15-03-02 |
Director/Board Member | 59 | - | |
Director/Board Member | 65 | 95-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.06% | 2 M€ | -.--% | - | |
2.06% | 2 M€ | +9.19% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 241.4 | -3.52% | 10 498 |
24-04-23 | 250.2 | +2.46% | 49,199 |
24-04-22 | 244.2 | +2.61% | 41,027 |
24-04-19 | 238 | +0.51% | 21,595 |
24-04-18 | 236.8 | -0.25% | 27,764 |
Delayed Quote Swiss Exchange, April 23, 2024 at 11:30 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.92% | 672B | |
+27.68% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+6.30% | 217B | |
+4.80% | 199B | |
-8.58% | 149B | |
-4.99% | 147B |
- Stock Market
- Equities
- ROG Stock
- RO Stock